IMGS-001

· ImmunoGenesis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMGS-001, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors [Phase 1]